• Author: Nina Cheranda
Clear all

The impact of race on survival and treatment in Veterans treated for metastatic castration-resistant prostate cancer

Abstract: Background: Black individuals have higher incidence and mortality rates of prostate cancer than White individuals, and existing literature on treatment sequencing …

Association of weight loss and BMI on PSA levels and overall survival in Veterans with metastatic castrate-resistant prostate cancer

Abstract: Background: There is a complex relationship between body weight and survival in prostate cancer. While increased BMI is associated with increased prostate cancer …

Hospitalizations among Veterans treated for metastatic prostate cancer with abiraterone or enzalutamide

Abstract: BACKGROUND: Abiraterone and enzalutamide are second generation androgen receptor pathway inhibitors (ARPIs) used to treat advanced or metastatic prostate cancer. Without …